|
C2CD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.343600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.777430E-01 |
| Normal-vs-Stage2 |
9.908400E-01 |
| Normal-vs-Stage3 |
2.689400E-01 |
| Normal-vs-Stage4 |
1.479950E-02 |
| Stage1-vs-Stage2 |
4.174600E-01 |
| Stage1-vs-Stage3 |
8.326000E-01 |
| Stage1-vs-Stage4 |
2.408000E-01 |
| Stage2-vs-Stage3 |
4.223400E-01 |
| Stage2-vs-Stage4 |
1.353980E-01 |
| Stage3-vs-Stage4 |
3.093000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.309200E-01 |
| Normal-vs-AfricanAmerican |
3.693000E-01 |
| Normal-vs-Asian |
8.860000E-01 |
| Caucasian-vs-AfricanAmerican |
7.314800E-01 |
| Caucasian-vs-Asian |
9.764800E-01 |
| AfricanAmerican-vs-Asian |
8.886600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.683800E-02 |
| Normal-vs-Female |
2.109800E-01 |
| Male-vs-Female |
7.201300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.993600E-01 |
| Normal-vs-Extreme_Weight |
2.505800E-02 |
| Normal-vs-Obese |
8.495000E-01 |
| Normal-vs-Extreme_Obese |
2.981800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.185800E-01 |
| Normal_Weight-vs-Obese |
1.813030E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.705200E-01 |
| Extreme_Weight-vs-Obese |
4.285900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.418800E-01 |
| Obese-vs-Extreme_Obese |
4.732200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.692400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.088000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.527810E-01 |
| Normal-vs-Age(81-100Yrs) |
1.364460E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.500600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.184970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.482220E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.082400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.754070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.473200E-01 |
| Normal-VS-Type2 PRCC |
2.976300E-04 |
| Normal-VS-KIRP CIMP |
3.047400E-01 |
| Normal-VS-Unclassified PRCC |
4.884000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.11240000003166E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.939200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.673200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.086000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.478600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.783200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.475600E-02 |
| Normal-vs-N1 |
7.960400E-01 |
| Normal-vs-N2 |
1.658560E-01 |
| N0-vs-N1 |
1.567250E-01 |
| N0-vs-N2 |
8.127600E-01 |
| N1-vs-N2 |
4.764600E-01 |
|
|
